The judge ruled in favor of HHS, saying that allowing Pfizer to run programs that reimburse patients for drugs would violate federal kickback law.
“Because the stated intent of the payments Pfizer proposes here are to increase the number of Medicare beneficiaries who purchase the drug, the court is unable to issue the declaratory judgment Pfizer seeks or to issue judgment in its favor,” Judge Mary Kay Vyskocil wrote.
The case was watched closely among drugmakers, as its ruling means they still cannot pay co-pays for patients enrolled in government-run insurance plans.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
